Analyzing the economics of a correspondent bank hedging program
Financial Institutions | Kennett Square, PA
The CEO of a community bank who actively uses a correspondent bank hedging program contacted Chatham and was looking to analyze pricing. They wanted better visibility into the economics of a $6.8M transaction the bank had recently executed.
- Understand the economics of the correspondent bank hedging program
- Gain visibility into the referral fee the correspondent bank paid the community bank
- Leveraged Chatham’s presence and experience in the capital markets, and compared the economics of the transaction and referral fee from the correspondent bank to what the community bank would have received had they offered the swap to their customer themselves
- Chatham’s RateManager program, a commercial loan hedging solution, would have delivered $154,000 more to the bank on a single $6.8M swap. The improved economics could have been recognized through fee income, loan spread, reducing the customer’s fixed rate or some combination of the three. Here are three illustrations:
We’d like to hear from you
Learn how to grow and optimize your interest rate swap program.
Chatham Hedging Advisors, LLC (CHA) is a subsidiary of Chatham Financial Corp. and provides hedge advisory, accounting and execution services related to swap transactions in the United States. CHA is registered with the Commodity Futures Trading Commission (CFTC) as a commodity trading advisor and is a member of the National Futures Association (NFA); however, neither the CFTC nor the NFA have passed upon the merits of participating in any advisory services offered by CHA. For further information, please visit chathamfinancial.com/legal-notices.
Transactions in over-the-counter derivatives (or “swaps”) have significant risks, including, but not limited to, substantial risk of loss. You should consult your own business, legal, tax and accounting advisers with respect to proposed swap transaction and you should refrain from entering into any swap transaction unless you have fully understood the terms and risks of the transaction, including the extent of your potential risk of loss. This material has been prepared by a sales or trading employee or agent of Chatham Hedging Advisors and could be deemed a solicitation for entering into a derivatives transaction. This material is not a research report prepared by Chatham Hedging Advisors. If you are not an experienced user of the derivatives markets, capable of making independent trading decisions, then you should not rely solely on this communication in making trading decisions. All rights reserved.20-0368
Our featured insights
Powell reaffirms commitment to accommodative policy stance
Despite the expectation of additional fiscal stimulus and dovish comments from the Federal Reserve chair, the major U.S. equity indices pulled back last week amid weak economic data, rising COVID-19 cases globally, and the continued emergence of new COVID-19 variants.
2020 Back-to-Back Swap Program Benchmark Statistics Report
Interested in seeing how your interest rate swap program stacks up relative to your peers? Perhaps your financial institution is not yet using swaps to win more commercial loan business, but would find value in reviewing and analyzing Chatham's Back-to-Back Swap Program Benchmark Statistics Report.
The three C’s of indirect swaps
Ben Lewis writes for Bank Director and discusses the concerns that bankers need to consider when choosing to work with correspondent banks that offer indirect swaps to their borrowers.
Democrats gain control of Senate, U.S. Capitol protests gain global attention
The major U.S. equity indices marched higher on the week, setting fresh all-time highs, as Democratic Party victories in the two Georgia Senate runoff elections gained the party control of the Senate fueling hopes for increased fiscal stimulus.
LIBOR transition enters crunch time in 2021
Bob Newman discusses the transition away from LIBOR with S&P Global Market Intelligence.
President Trump signs COVID-19 relief bill
The major U.S. equity indices ended the final week of the year on a high note, setting new all-time highs, as the passage of a federal stimulus bill and continued distribution of two COVID-19 vaccines in the U.S. dominated headlines and improved investor sentiment.
Agreement reached on COVID-19 relief bill
The major U.S. equity indices finished higher for the week, setting new all-time highs, as the expectation of federal stimulus and the approval of a second COVID-19 vaccine fueled investor optimism despite worsening economic data and rising COVID-19 cases.
Vaccine approved amid surge in cases
Despite COVID-19 vaccine developments and renewed stimulus bill hope, the major U.S. equity indices moved lower for the week as the continued rise in COVID-19 cases and the recent return of virus-related restrictions in many regions dampened investor sentiment and darkened the economic outlook.